AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PARACETAMOL/DICLOFENAC/CAFFEINE

14 registrations across 1 African market— 14 active

Markets with PARACETAMOL/DICLOFENAC/CAFFEINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
RONAMOL TABLETS (Each tablet contains Paracetamol/ Diclofenac/ Caffeine🇬🇭GhanaactiveMay 2031
RONAMOL PLUS TABLETS (Each tablet contains Paracetamol/ Diclofenac/ Caffeine🇬🇭GhanaactiveMay 2031
RONAMOL FORTE TABLETS (Each tablet contains Paracetamol/ Diclofenac/ Caffeine🇬🇭GhanaactiveMay 2031
RONAMOL PLUS TABLETS (Each tablet contains Paracetamol/ Diclofenac/ Caffeine🇬🇭GhanaactiveMay 2031
RONAMOL TABLETS (Each tablet contains Paracetamol/ Diclofenac/ Caffeine🇬🇭GhanaactiveMay 2031
RONAMOL FORTE TABLETS (Each tablet contains Paracetamol/ Diclofenac/ Caffeine🇬🇭GhanaactiveMay 2031
TRAFIT FORTE CAPSULES🇬🇭GhanaactiveDec 2027
TRAFIT FORTE CAPSULES🇬🇭GhanaactiveDec 2027
PELADOL EXTRA TABLETS🇬🇭GhanaactiveDec 2026
PELADOL EXTRA TABLETS🇬🇭GhanaactiveDec 2026
CAPEM CAPSULES🇬🇭GhanaactiveDec 2026
ASDOL EXTRA TABLETS🇬🇭GhanaactiveDec 2026
ASDOL EXTRA TABLETS🇬🇭GhanaactiveDec 2026
CAPEM CAPSULES🇬🇭GhanaactiveDec 2026

PARACETAMOL/DICLOFENAC/CAFFEINE in Africa — Regulatory Overview

PARACETAMOL/DICLOFENAC/CAFFEINE is registered across 1 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana. AfricaRegulatory refreshes this data daily from official government sources.

Of the 14 registrations, 14 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.